Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.97 |
| ▸ | MEN1 | O00255 | 1/20 | 0.97 |
| ▸ | RGS12 | O14924 | 1/20 | 0.97 |
| ▸ | NPC1 | O15118 | 1/20 | 0.97 |
| ▸ | USP2 | O75604 | 1/20 | 0.97 |
| ▸ | LMNA | P02545 | 1/20 | 0.97 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.97 |
| ▸ | THRB | P10828 | 1/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.97 |
| ▸ | HTT | P42858 | 1/20 | 0.97 |
| ▸ | RAD52 | P43351 | 1/20 | 0.97 |
| ▸ | RAB9A | P51151 | 1/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.97 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.97 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.97 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.97 |
| ▸ | BCHE | P06276 | 13/20 | 0.82 |
| ▸ | ACHE | P22303 | 13/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9319117 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL1960573 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL4068375 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL29721510 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL4061564 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL4071951 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL1412685 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL1412766 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| Bromide SCHEMBL3359102 | 0.98 | KDM4E (0.93) | KDM4EMEN1RGS12NPC1USP2 | |
| Hydrochloric Acid SCHEMBL780409 | 0.98 | KDM4E (0.93) | KDM4EMEN1RGS12NPC1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110144079-A1 | ANTIMICROBIAL SYSTEM | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2011-06-16 | — | — | US | claimed |
| EP-0340421-A2 | Conducting varnish composition | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1989-11-08 | — | — | EP | claimed |
| EP-4693565-A1 | ELECTROLYTE FOR ANODE-FREE LITHIUM METAL BATTERY AND ANODE-FREE LITHIUM METAL BATTERY COMPRISING SAME | Samsung SDI Co., Ltd. (KR) | 2026-02-11 | — | — | EP | disclosed |
| EP-4693569-A1 | ELECTROLYTE AND LITHIUM BATTERY COMPRISING SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-02-11 | — | — | EP | disclosed |
| US-12438150-B2 | Anodeless lithium metal battery and method of manufacturing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-10-07 | — | — | US | disclosed |
| US-12431539-B2 | All-solid secondary battery and method of preparing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-09-30 | — | — | US | disclosed |
| US-20250253393-A1 | BILAYER COMPONENT FOR A LITHIUM BATTERY | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-08-07 | — | — | US | disclosed |
| US-12347827-B2 | Bilayer component for a lithium battery | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-07-01 | — | — | US | disclosed |
| US-12334548-B2 | Anodeless lithium metal battery and method of manufacturing the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-06-17 | — | — | US | disclosed |
| US-20250192227-A1 | AMORPHOUS NITROGEN-RICH SOLID STATE LITHIUM ELECTROLYTE | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-06-12 | — | — | US | disclosed |
| US-12211971-B2 | Amorphous nitrogen-rich solid state lithium electrolyte | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-01-28 | — | — | US | disclosed |
| EP-2991153-A1 | COMPOSITE ELECTROLYTE AND LITHIUM BATTERY INCLUDING THE SAME | Samsung Electronics Co., Ltd. (KR) | 2016-03-02 | — | — | EP | disclosed |
| US-20110144079-A1 | ANTIMICROBIAL SYSTEM | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2011-06-16 | — | — | US | disclosed |
| WO-2009040107-A2 | METHOD FOR THE PRODUCTION OF METAL-CONTAINING NANOPARTICLES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009024312-A2 | METHOD FOR THE PRODUCTION AND STABILIZATION OF FUNCTIONAL METAL NANOPARTICLES IN IONIC LIQUIDS | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-02-26 | — | — | WO | disclosed |
| US-7087353-B2 | Non-contact heat fixing toner | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2006-08-08 | — | — | US | disclosed |
| US-20040142263-A1 | Non-contact heat fixing toner | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. | 2004-07-22 | — | — | US | disclosed |
| EP-0661598-B1 | Decolorizable toner and a decolorizable toner production process | SHOWA DENKO KK (JP) | 1998-09-16 | — | — | EP | disclosed |
| US-5607803-A | Decolorizable toner and a decolorizable toner production process | SHOWA DENKO K.K. (JP) | 1997-03-04 | — | — | US | disclosed |
| EP-0661598-A1 | Decolorizable toner and a decolorizable toner production process | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1995-07-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12431539-B2 | All-solid secondary battery and method of preparing the same | SLC9B2, ASH2L, SETDB1 | KDM4E 2139/4885MEN1 1666/4885RGS12 4519/4885 |
| US-20110144079-A1 | ANTIMICROBIAL SYSTEM | PIK3C3, POLR1C, LTN1 | KDM4E 3065/4885MEN1 4090/4885RGS12 2540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.